Volume | 188,459 |
|
|||||
News | - | ||||||
Day High | 0.79 | Low High |
|||||
Day Low | 0.733 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Virpax Pharmaceuticals Inc | VRPX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.79 | 0.733 | 0.79 | 0.7731 | 0.781 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
632 | 188,459 | $ 0.7605578 | $ 143,334 | - | 0.68 - 11.774 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:02:52 | formt | 437 | $ 0.7662 | USD |
Virpax Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
890.29k | 1.17M | - | 0 | -15.19M | -12.97 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Virpax Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRPX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.55 | 3.14 | 0.68 | 0.8641094 | 729,517 | -1.78 | -69.95% |
1 Month | 3.55 | 3.6472 | 0.68 | 0.9652438 | 193,667 | -2.78 | -78.42% |
3 Months | 3.49 | 5.48 | 0.68 | 1.90 | 93,530 | -2.72 | -78.05% |
6 Months | 7.101 | 7.199 | 0.68 | 3.33 | 199,811 | -6.33 | -89.21% |
1 Year | 7.70 | 11.774 | 0.68 | 4.04 | 114,144 | -6.93 | -90.05% |
3 Years | 39.90 | 359.799 | 0.68 | 103.17 | 716,356 | -39.13 | -98.08% |
5 Years | 80.00 | 359.799 | 0.68 | 102.10 | 673,064 | -79.23 | -99.04% |
Virpax Pharmaceuticals Description
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. |